Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Kainomyx to support the development and production of new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in OliLux Biosciences to support the development of diagnostic and treatment monitoring tools for the detection and management of tuberculosis.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VasoRX to support work testing a new therapy for vascular diseases such as atherosclerosis and pulmonary arterial hypertension.